PRLD — PRELUDE THERAPEUTICS INC

Ownership history in ORBIMED ADVISORS LLC  ·  22 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in PRELUDE THERAPEUTICS INC (PRLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
9.76% (2020 Q4)
Avg. % of fund
1.81%
First filed
2020 Q3
Last filed
2025 Q4
Quarters held
22
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 10,909,256 — 0% 0.65% $31.6M $2.90
2025 Q3 UNCHANGED 10,909,256 — 0% 0.37% $15.7M $1.44
2025 Q2 UNCHANGED 10,909,256 — 0% 0.22% $8.8M $0.81
2025 Q1 UNCHANGED 10,909,256 — 0% 0.20% $8.4M $0.77
2024 Q4 UNCHANGED 10,909,256 — 0% 0.29% $13.9M $1.27
2024 Q3 UNCHANGED 10,909,256 — 0% 0.41% $22.6M $2.07
2024 Q2 UNCHANGED 10,909,256 — 0% 0.82% $41.6M $3.81
2024 Q1 UNCHANGED 10,909,256 — 0% 0.95% $51.7M $4.74
2023 Q4 UNCHANGED 10,909,256 — 0% 0.93% $46.6M $4.27
2023 Q3 UNCHANGED 10,909,256 — 0% 0.72% $33.7M $3.09
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PRLD price (monthly, adj. close)

Other funds also holding PRLD

As of 2025 Q4 — sorted by position size

BAKER BROS. ADVISORS LP 3Y 7Y 0.17% Kynam Capital Management, LP 3Y 0.15% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.07% XTX Topco Ltd 3Y 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% ACADIAN ASSET MANAGEMENT LLC 3Y 7Y 0.0% CALDWELL SUTTER CAPITAL, INC. 3Y 0.0% OMERS ADMINISTRATION Corp 3Y 7Y 0.0% TWO SIGMA ADVISERS, LP 3Y 7Y 0.0%
← Back to ORBIMED ADVISORS LLC Holdings